Lithuanian cohort of Chernobyl cleanup workers: Cancer incidence follow-up 1986–2012

2021 ◽  
Vol 74 ◽  
pp. 102015
Author(s):  
Giedre Smailyte ◽  
Auguste Kaceniene ◽  
Rita Steponaviciene ◽  
Ausrele Kesminiene
2013 ◽  
Vol 33 (2) ◽  
pp. 395-411 ◽  
Author(s):  
Kaja Rahu ◽  
Anssi Auvinen ◽  
Timo Hakulinen ◽  
Mare Tekkel ◽  
Peter D Inskip ◽  
...  

Author(s):  
V.V. Kashcheev ◽  
◽  
S.Yu. Chekin ◽  
S.V. Karpenko ◽  
M.A. Maksioutov ◽  
...  

The paper considers radiation risks of solid cancer incidence and mortality, as well as risk of leu-kemia incidence (other than chronic lymphocytic leukemia) among Russian Chernobyl cleanup workers (liquidators). The study of the cohort of liquidators carried out at the National Radiation Epidemiological Registry (NRER) was based on the follow-up data collected from 1992 over 2019. The size of the Chernobyl cleanup workers cohort exceeded 65 thousand people, their av-erage age at the time of entering the exclusion zone was 34 years, the average external gamma radiation dose received by liquidators during their cleanup work was about 0.133 Gy. Radiation-induced risks of solid cancer incidence and mortality in the study cohort were statistically signifi-cant, the risk magnitude rose with increasing the follow-up length. For the maximum follow-up period, from 1992 over 2019, the excess relative risk coefficient for solid cancer incidence was ERR/Gy=0.62, 95% CI (0.29; 0.98), and excess relative risk coefficient for solid cancer mortality was ERR/Gy=0.74, 95% CI (0.32; 1.22), the estimated coefficients were in good agreement with similar coefficients calcu-lated for the Russian liquidators with the use of ICRP radiation risk models. Non-parametric esti-mates of relative radiation risk within the same dose intervals for solid cancers and for leukemias in the cohort of liquidators were statistically significant for radiation doses above 0.150 Gy. For radiation doses below 0,150 Гр the linear non-threshold model is conservative, i.e. there was ev-idence for statistically significant radiation risk of leukemia incidence among liquidators during the first 11 years after the accident, from 1986 over 1997, ERR/Gy=4.41, 95% CI (0.24; 14.23). In later years, until 2018 there was no evidence of radiation-related risk of leukemia incidence. Out-comes of future studies will impact on optimization of radiological protection, development of reference levels for Russian general public exposure and improvement of the system for delivery of targeted medical care to people exposed to radiation.


GastroHep ◽  
2021 ◽  
Vol 3 (2) ◽  
pp. 107-115
Author(s):  
Inka Koskinen ◽  
Kaisa Hervonen ◽  
Eero Pukkala ◽  
Timo Reunala ◽  
Katri Kaukinen ◽  
...  

Public Health ◽  
2020 ◽  
Vol 181 ◽  
pp. 189-195 ◽  
Author(s):  
F. Hadaegh ◽  
S. Asgari ◽  
P. Hashemi ◽  
A. Baghbani-Oskouei ◽  
F. Eskandari ◽  
...  
Keyword(s):  

2021 ◽  
pp. 1-7
Author(s):  
Eero Pukkala ◽  
Miikka Peltomaa ◽  
Antti Mäkitie ◽  
Sanna Heikkinen ◽  
Kristina Kjærheim ◽  
...  

2021 ◽  
Author(s):  
Kajsa Sjöholm ◽  
Lena MS Carlsson ◽  
Per-Arne Svensson ◽  
Johanna C. Andersson-Assarsson ◽  
Felipe Kristensson ◽  
...  

<b>OBJECTIVE</b> <p>Obesity and type 2 diabetes are associated with serious, adverse health effects, including cancer. Although bariatric surgery has been shown to reduce cancer risk in patients with obesity, the effect of bariatric surgery on cancer risk in patients with obesity and diabetes is less studied. We therefore examined the long-term incidence of cancer after bariatric surgery and usual care in patients with obesity and diabetes in the matched prospective Swedish Obese Subjects (SOS) study. </p> <p><b>RESEARCH DESIGN AND METHODS</b></p> <p>The SOS study examines long-term outcomes following bariatric surgery or usual care. The current analysis includes 701 patients with obesity and type 2 diabetes at baseline, 393 of which underwent bariatric surgery, and 308 who received conventional obesity treatment. Information on cancer events was obtained from the Swedish National Cancer Register. Median follow-up time was 21.3 years (interquartile range 17.6-24.8 years, maximum 30.7 years). </p> <p><b>RESULTS</b></p> <p>During follow-up, the incidence rate for first-time cancer was 9.1 per 1000-person-years (95% CI, 7.2-11.5) in patients with obesity and diabetes treated with bariatric surgery and 14.1 per 1000-person-years (95% CI, 11.2-17.7) in patients treated with usual obesity care (HRadj=0.63; 95% CI 0.44-0.89, p=0.008). Moreover, surgery was associated with reduced cancer incidence in women (HRadj=0.58; 0.38-0.90, p=0.016), although the sex-treatment interaction was non-significant (p=0.630). In addition, diabetes remission at the 10-year follow-up was associated with reduced cancer incidence (HRadj=0.40; 95% CI 0.22-0.74, p=0.003).</p> <p><b>CONCLUSIONS</b></p> <p>These results suggest that bariatric surgery prevents cancer in patients with obesity and diabetes, and that durable diabetes remission is associated with reduced cancer risk. </p>


2017 ◽  
Vol 74 (11) ◽  
pp. 823-826 ◽  
Author(s):  
Per Gustavsson ◽  
Tomas Andersson ◽  
Annika Gustavsson ◽  
Christina Reuterwall

Sign in / Sign up

Export Citation Format

Share Document